SCHEMBL21394643

SCHEMBL21394643

Cc1cc(C(=O)Nc2ccc(Cc3cc(F)cc(F)c3)cn2)cnc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
RAB9A P51151 4/20 0.44
ALDH1A1 P00352 3/20 0.44
NPC1 O15118 3/20 0.44
TSHR P16473 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
PKM P14618 1/20 0.44
KMT2A Q03164 1/20 0.43
GCK P35557 2/20 0.42
TP53 P04637 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
ABCB1 P08183 1/20 0.41
ABCC1 P33527 1/20 0.41
F10 P00742 1/20 0.41
CXCR2 P25025 2/20 0.41
DEGS1 O15121 1/20 0.40
POLB P06746 1/20 0.39
RARG P13631 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21394731 0.90 CYP3A4 (0.42) GCK
SCHEMBL21394727 0.89 KMT2A (0.50) KDM4ERAB9AALDH1A1NPC1TSHR
SCHEMBL21394395 0.85 KDM4E (0.49) KDM4ERAB9AALDH1A1NPC1TSHR
SCHEMBL21394694 0.84 GCK (0.42) KDM4ERAB9AALDH1A1NPC1TSHR
SCHEMBL21395030 0.81 NPC1 (0.45) KDM4ERAB9AALDH1A1NPC1TSHR
SCHEMBL21394726 0.80 RAB9A (0.42) RAB9AALDH1A1NPC1TSHRSMN1; SMN2
SCHEMBL21395156 0.80 KDM4E (0.42) KDM4ERAB9AALDH1A1NPC1TSHR
SCHEMBL21395009 0.79 PARP1 (0.53) KDM4ERAB9AALDH1A1NPC1TSHR
SCHEMBL21394393 0.78 NPC1 (0.43) KDM4ERAB9AALDH1A1NPC1TSHR
SCHEMBL21394654 0.77 WNT3A (0.44) KDM4ERAB9AALDH1A1NPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020198026-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed
WO-2019183587-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed